Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,802 | 79,558 | 130,104 | 57,526 | 56,617 |
| Marketable Securities | 215,403 | 243,740 | 137,765 | 177,161 | 198,843 |
| Receivables | 25,347 | 20,199 | 18,192 | 20,473 | 23,604 |
| Other current assets | 19,472 | 19,479 | 16,082 | 13,774 | 23,330 |
| TOTAL | $331,967 | $373,752 | $313,237 | $278,001 | $313,396 |
| Non-Current Assets | |||||
| PPE Net | 107,515 | 111,017 | 114,497 | 117,589 | 120,551 |
| Investments And Advances | 27,838 | 40,296 | 4,858 | 10,179 | 23,108 |
| Other Non-Current Assets | 57,883 | 55,962 | 58,337 | 60,220 | 62,059 |
| TOTAL | $193,236 | $207,275 | $177,692 | $187,988 | $205,718 |
| Total Assets | $525,203 | $581,027 | $490,929 | $465,989 | $519,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,266 | 21,655 | 19,044 | 22,798 | 19,522 |
| Accrued Expenses | 38,316 | 35,557 | 23,597 | 38,070 | 48,642 |
| Other current liabilities | 41,718 | 40,302 | 42,560 | 34,309 | 26,697 |
| TOTAL | $124,568 | $119,540 | $106,731 | $103,194 | $102,725 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,195 | 13,977 | 13,588 | 115 | 144 |
| Other Non-Current Liabilities | 217,997 | 224,004 | 83,704 | 103,144 | 114,973 |
| TOTAL | $239,183 | $247,808 | $110,001 | $103,144 | $114,973 |
| Total Liabilities | $363,751 | $367,348 | $216,732 | $206,338 | $217,698 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,623 | 50,514 | 50,160 | 50,086 | 49,545 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,058,878 | -996,937 | -926,066 | -932,149 | -880,963 |
| Other shareholders' equity | -652 | -750 | -762 | -741 | -582 |
| TOTAL | $161,452 | $213,679 | $274,197 | $259,651 | $301,416 |
| Total Liabilities And Equity | $525,203 | $581,027 | $490,929 | $465,989 | $519,114 |